Innovation Pharmaceuticals Inc.
IPIX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $6,220 | $10,367 | $9,939 | $9,580 |
| - Cash | $864 | $1,518 | $1,940 | $2,423 |
| + Debt | $238 | $268 | $346 | $393 |
| Enterprise Value | $5,594 | $9,117 | $8,345 | $7,550 |
| Revenue | $0 | -$6 | $0 | $0 |
| % Growth | 100% | – | – | – |
| Gross Profit | -$88 | -$99 | -$94 | $0 |
| % Margin | – | 1,650% | – | – |
| EBITDA | -$772 | -$579 | -$585 | -$253 |
| % Margin | – | 9,650% | – | – |
| Net Income | -$880 | -$681 | -$729 | -$361 |
| % Margin | – | 11,350% | – | – |
| EPS Diluted | -0.002 | -0.001 | -0.002 | -0.001 |
| % Growth | -30.8% | 13.3% | -114.3% | – |
| Operating Cash Flow | -$677 | -$369 | -$469 | -$477 |
| Capital Expenditures | -$2 | -$12 | -$17 | -$27 |
| Free Cash Flow | -$679 | -$381 | -$486 | -$504 |